The powerful consulting firm McKinsey will"accept responsibility" and pay $650 million for helping to fuel the opioid crisis, but executives will once again dodge prosecution.The global consulting firm McKinsey and Company Friday agreed to pay $650 million to settle a federal probe into its role in helping"turbocharge" sales of the highly addictive opioid painkiller OxyContin for Purdue Pharma, the U.S. Justice Department announced on Friday.
That means unless it commits additional wrongdoing linked to opioids, the other executives who led McKinsey during years when it helped drug companies boost prescription opioid sales won't face criminal charges or trial.sent to NPR. The firm also apologized for"the actions of a former partner who deleted documents related to his work for that client.
DOJ officials said the misdemeanor offense involved"knowingly and intentionally conspiring with Purdue and others to aid and abet the misbranding of prescription drugs." Bisch noted the DOJ frequently prosecutes street level drug dealers, physicians and"pill mill" pharmacy operators accused of wrongdoing linked to opioids. They often wind up serving lengthy prison sentences.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KPBSnews - 🏆 240. / 63 Read more »
Source: sdut - 🏆 5. / 95 Read more »
Source: wjxt4 - 🏆 246. / 63 Read more »
Source: KPRC2 - 🏆 80. / 68 Read more »
Source: NBCNewYork - 🏆 270. / 63 Read more »
Source: AP - 🏆 728. / 51 Read more »